Clinical Study Agreement Template for the United Arab Emirates

A Clinical Study Agreement is a comprehensive legal contract that governs the conduct of clinical trials and medical research in the United Arab Emirates. This document establishes the contractual relationship between pharmaceutical companies, healthcare institutions, principal investigators, and other parties involved in clinical research, ensuring compliance with UAE federal laws and regulatory requirements.

When do you need this document?

You need a Clinical Study Agreement when conducting any clinical trial or medical research study in UAE healthcare facilities. This includes pharmaceutical companies testing new medications, medical device manufacturers conducting safety and efficacy studies, and research organizations performing observational studies or clinical investigations. The agreement is mandatory when multiple parties collaborate on research projects, particularly when involving international sponsors working with local UAE healthcare institutions. You also require this document when contract research organizations are engaged to manage clinical trials on behalf of sponsors, or when conducting multi-center studies across different emirates with varying local health authority requirements.

Key legal considerations

The agreement must address several critical legal aspects to ensure proper study conduct and regulatory compliance. Patient safety and protection provisions are paramount, including detailed protocols for informed consent, adverse event reporting, and safety monitoring procedures. Financial arrangements require careful structuring to cover study costs, investigator payments, and potential liability issues while complying with UAE healthcare payment regulations. Data protection and confidentiality clauses must align with UAE privacy laws and international standards for clinical data management. Insurance and indemnification provisions are essential to protect all parties from potential liabilities arising from the study conduct. The agreement should also establish clear intellectual property rights, publication policies, and procedures for study termination or suspension.

Legal requirements in United Arab Emirates

UAE clinical study agreements must comply with Federal Law No. 4 of 2016 governing medical liability and healthcare practices, which includes specific provisions for medical research and experimentation. Cabinet Resolution No. 28 of 2018 establishes detailed regulations for clinical research conduct, requiring adherence to international good clinical practice standards while meeting local regulatory expectations. Federal Law No. 8 of 2019 regulates medical products and investigational medicinal products used in clinical trials, mandating specific approval processes and safety monitoring requirements. The agreement must incorporate MOHAP Guidelines for Clinical Trials, which specify approval processes, ethics committee requirements, and ongoing safety reporting obligations. Additionally, compliance with Federal Law No. 2 of 2019 regarding ICT use in healthcare is necessary for electronic data collection and management systems. Local health authority requirements from DHA, DOH, or DHCC may impose additional obligations depending on the study location within the UAE.